Research notes,
lab methods,
compound profiles.
Editorial dispatches from the NZM research desk — receptor pharmacology, protocol-design notes, lab-method walkthroughs, and frontier-science explainers. Written for researchers, in plain language.
More from the desk.
Solid-Phase Peptide Synthesis: How Research-Grade Peptides Are Actually Made
Solid-phase peptide synthesis is the chemistry behind every research peptide in the modern catalog: how the process works, why it governs purity, and how to read…
Retatrutide vs Tirzepatide: Triple-Agonist vs Dual-Agonist Mechanism
Both are incretin-mimetic research peptides, but they engage categorically different receptor combinations. The mechanism distinction is what determines which one suits a given protocol.
Retatrutide vs Semaglutide: Triple-Agonist vs Single-Pathway GLP-1
Semaglutide engages one receptor; Retatrutide engages three. The mechanism gap is wider than the family relationship suggests, and it changes what each compound is useful for…
Retatrutide vs Ozempic: Research Compound vs Branded GLP-1
Ozempic is the branded prescription form of semaglutide. Retatrutide is a research-grade triple-agonist peptide. The names sit in different worlds, and the comparison researchers are usually…
PT-141: Nasal vs Injection Route Pharmacokinetics
PT-141 (bremelanotide) is studied across two delivery routes, intranasal and subcutaneous. The pharmacokinetic profiles diverge, and the choice of route is a research-design variable, not a…
Mounjaro vs Ozempic: Tirzepatide (Dual Agonist) vs Semaglutide (GLP-1)
Mounjaro and Ozempic look like sibling products but contain different molecules. Mounjaro's compound activates two incretin receptors; Ozempic's compound activates one, and that mechanism gap is…
Copper Peptides: Chemistry, Mechanism, and Dermal-Research Applications
GHK-Cu is the most-cited copper peptide in dermal-research literature, but the wider class of tripeptide-copper complexes, including AHK-Cu, is what defines the category.
GLP-1, GIP, and Glucagon: How Receptor Profile Shapes Research Outcomes
Single-pathway, dual, and triple agonists produce categorically different downstream effects. The receptor profile a molecule activates is the most consequential decision in any modern incretin-mimetic protocol.
Why Janoshik Analytical: A Researcher’s Guide to Independent Lab Verification
Independent third-party verification is the only credible way to certify what's actually in a research-grade peptide vial. Here's why Janoshik is the European reference, and what…